Maturation of pluripotent stem cell-derived cardiomyocytes: limitations and challenges from metabolic aspects
Abstract Acute coronary syndromes, such as myocardial infarction (MI), lack effective therapies beyond heart transplantation, which is often hindered by donor scarcity and postoperative complications. Human induced pluripotent stem cells (hiPSCs) offer the possibility of myocardial regeneration by d...
Prif Awduron: | Xi Jiang, Xin Lian, Kun Wei, Jie Zhang, Kaihua Yu, Haoming Li, Haichun Ma, Yin Cai, Lei Pang |
---|---|
Fformat: | Erthygl |
Iaith: | English |
Cyhoeddwyd: |
BMC
2024-10-01
|
Cyfres: | Stem Cell Research & Therapy |
Pynciau: | |
Mynediad Ar-lein: | https://doi.org/10.1186/s13287-024-03961-4 |
Eitemau Tebyg
-
Maturation of induced pluripotent stem cell-derived cardiomyocytes and its therapeutic effect on myocardial infarction in mouse
gan: Peng Wu, et al.
Cyhoeddwyd: (2023-02-01) -
Characterization of cardiac metabolism in iPSC-derived cardiomyocytes: lessons from maturation and disease modeling
gan: Sofija Vučković, et al.
Cyhoeddwyd: (2022-07-01) -
iPSC-Derived Cardiomyocytes in Inherited Cardiac Arrhythmias: Pathomechanistic Discovery and Drug Development
gan: Eline Simons, et al.
Cyhoeddwyd: (2023-01-01) -
Modeling hypertrophic cardiomyopathy with human cardiomyocytes derived from induced pluripotent stem cells
gan: Jiangtao Li, et al.
Cyhoeddwyd: (2022-06-01) -
Metabolic Maturation Exaggerates Abnormal Calcium Handling in a <i>Lamp2</i> Knockout Human Pluripotent Stem Cell-Derived Cardiomyocyte Model of Danon Disease
gan: Robert J. Barndt, et al.
Cyhoeddwyd: (2022-12-01)